-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Astrana Health, Raises Price Target to $45

Benzinga·11/06/2026 11:16:02
Diffusion vocale
Needham analyst Matthew Shea maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $41 to $45.